Biolytics partners with high-potential healthcare ventures to unlock enterprise growth, clinical validation, regulatory clarity, and capital access. Not an accelerator. A growth architecture firm built from operator experience.
Biolytics was founded on a conviction that healthcare's most important companies don't need a 12-week cohort — they need a partner who operates in the trenches with them.
"The healthcare companies that matter don't get built in cohorts. They get built in the field — through relentless iteration, deep clinical insight, and access to the right doors at the right time."
Biolytics — Founding PrincipleStandard programs trade depth for scale. We do the opposite. Fewer partnerships, longer commitment, deeper involvement. Think of us as an embedded growth function — not a service you subscribe to.
12–16 weeks, a graduation ceremony, and you're on your own.
We stay engaged until the milestone is hit — not until the calendar says so.
30–50 companies per cohort. Surface-level mentorship at best.
A small number of ventures per year. We are operationally in the room with you.
We operate across every dimension of healthcare company scaling — from your first enterprise conversation to capital raise readiness.
A structured but flexible engagement model built around your specific growth constraints — not a generic syllabus.
We map your growth blockers, market position, regulatory standing, and capital runway before any engagement begins.
Co-create a bespoke growth plan — identifying the high-leverage vectors that will move your business fastest.
Our team operates alongside yours — opening doors, structuring deals, navigating regulatory processes, securing capital.
Build the infrastructure, governance, and investor narrative required for your next funding milestone.
Point-of-care diagnostics, AI-assisted radiology, pathology automation, and lab-on-chip platforms are rewriting how disease is detected in India. We have the network and expertise to fast-track clinical validation and market entry.
Surgical robotics, wearable vital monitors, minimally invasive tools — device companies face rigorous clinical validation and complex enterprise procurement. We've mapped these corridors in detail.
EHR integration, clinical decision support, remote patient monitoring. We help AI health companies move from prototype to production inside real hospital and payer ecosystems — where most fail.
Personalised therapeutics, genomic diagnostics, and biosimilar development require a patient, specialised growth strategy. We partner with founders building at the frontier of biology and computation.
We are building our advisory council from operators, clinicians, and investors with real healthcare company-building experience.
We are building our founding portfolio — a small group of healthcare ventures we will work with at the deepest level. We are not running a large cohort. We are looking for the right founders.
"We'd rather partner with three companies and change their trajectory than take thirty and skim the surface."
You're a good fit if you're a healthcare or life sciences founder who has moved past idea stage, has some validation in hand, and is facing the hard problems of distribution, regulation, or enterprise sales that technology alone cannot solve.
We review every application personally. Expect a response within 5 business days.